Cargando…
Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
Since the publication of the SIMPLE and NORDIC trials, defibrillation testing (DFT) is rarely performed during routine implantation of transvenous implantable cardioverter-defibrillators (ICD). However, the results of these trials cannot be extrapolated to the later introduced subcutaneous ICD (S-IC...
Autores principales: | van der Stuijt, W., Quast, A. B. E., Knops, R. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419406/ https://www.ncbi.nlm.nih.gov/pubmed/32780342 http://dx.doi.org/10.1007/s12471-020-01448-4 |
Ejemplares similares
-
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
por: de Veld, Jolien A, et al.
Publicado: (2023) -
Long‐term follow‐up of the two‐incision implantation technique for the subcutaneous implantable cardioverter‐defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020) -
Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020) -
High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors’ reply
por: van der Stuijt, Willeke, et al.
Publicado: (2021) -
Complications related to elective generator replacement of the subcutaneous implantable defibrillator
por: van der Stuijt, Willeke, et al.
Publicado: (2020)